Helixmith Co., Ltd (KOSDAQ:084990)
South Korea · Delayed Price · Currency is KRW 5,660.00
+210.00 (3.85%)
Nov 20, 2025, 3:30 PM KST
Helixmith Market Cap
Helixmith has a market cap or net worth of 250.96 billion as of November 19, 2025. Its market cap has increased by 50.34% in one year.
Market Cap
250.96B
Enterprise Value
169.03B
Revenue
4.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,660.00
Market Cap Chart
Since December 29, 2005, Helixmith's market cap has increased from 238.64B to 250.96B, an increase of 5.16%. That is a compound annual growth rate of 0.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 250.96B | 101.85% |
| Dec 30, 2024 | 124.33B | -51.50% |
| Dec 28, 2023 | 256.37B | -35.45% |
| Dec 29, 2022 | 397.14B | -53.54% |
| Dec 30, 2021 | 854.88B | -3.11% |
| Dec 30, 2020 | 882.29B | -55.53% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 41.83T |
| ALTEOGEN | 29.31T |
| SK Biopharmaceuticals | 10.20T |
| ABL Bio | 9.70T |
| Yuhan | 9.35T |
| Peptron | 7.30T |
| HLB Co., Ltd. | 6.50T |